A recent Pennsylvania court ruling on Risperdal lawsuits leaves drug manufacturer Johnson & Johnson open to claims for punitive damages. The lawsuits allege that the drug Risperdal caused men to grow breasts.The condition is known as gynecomastia. The cases will now be tried under New... Read More

In early January, Johnson & Johnson and its Janssen Pharmaceuticals unit agreed to enter into a settlement in advance of trial in a case brought by male plaintiff who alleged that the drug maker's antipsychotic medication Risperdal caused unwanted breast growth. The resolution of this... Read More

The most recent Risperdal lawsuit slated to go before a jury ended in a settlement before the trial even began. Risperdal manufacturer Johnson & Johnson agreed to settle the case for an undisclosed amount, possibly avoiding another massive judgement that has characterized recent Risperdal trials. The latest case, which was... Read More

A Tennessee teen has prevailed against drug giant Johnson & Johnson (J & J) and its Janssen unit, receiving a jury verdict in his favor and an award of $70 million in a Risperdal gynecomastia lawsuit. The jurors in the case found that officials from... Read More

In the heat of debate over how antipsychotic prescriptions may impact the health of children, a new study solidifies the link between the medications and diabetes. The medical journal JAMA Psychiatry released the report of the study late last month and the results indicate that... Read More

The U.S. Government Accountability Office (GAO) has released a report to the Subcommittee on Labor, Health, and Human Services of the House of Representatives detailing what it calls “problems with (the FDA’s) postmarket safety data.” The GAO report claims that the FDA “lacks reliable, readily... Read More

Johnson & Johnson’s attempt to get the U.S. Supreme Court to overturn a $124 million Risperdal verdict has been denied. The pharmaceutical giant has been fighting the verdict in the case brought by the state of South Carolina since 2011. The company’s final hope for... Read More

The fourth Risperdal trial to date has resulted in a $500,000 award for the plaintiff. It took just six hours of deliberations for the Philadelphia jury to find in favor of the plaintiff in the case of Timothy Stange v. Janssen Pharmaceuticals. Calling the verdict “another... Read More